{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:58:22Z","timestamp":1778745502383,"version":"3.51.4"},"reference-count":40,"publisher":"American Diabetes Association","issue":"8","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":3331,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,8,1]]},"abstract":"<jats:sec>\n                  <jats:title\/>\n                  <jats:p>We previously used Gene Expression Signature technology to identify methazolamide (MTZ) and related compounds with insulin sensitizing activity in vitro. The effects of these compounds were investigated in diabetic db\/db mice, insulin-resistant diet-induced obese (DIO) mice, and rats with streptozotocin (STZ)-induced diabetes. MTZ reduced fasting blood glucose and HbA1c levels in db\/db mice, improved glucose tolerance in DIO mice, and enhanced the glucose-lowering effects of exogenous insulin administration in rats with STZ-induced diabetes. Hyperinsulinemic-euglycemic clamps in DIO mice revealed that MTZ increased glucose infusion rate and suppressed endogenous glucose production. Whole-body or cellular oxygen consumption rate was not altered, suggesting MTZ may inhibit glucose production by different mechanism(s) to metformin. In support of this, MTZ enhanced the glucose-lowering effects of metformin in db\/db mice. MTZ is known to be a carbonic anhydrase inhibitor (CAI); however, CAIs acetazolamide, ethoxyzolamide, dichlorphenamide, chlorthalidone, and furosemide were not effective in vivo. Our results demonstrate that MTZ acts as an insulin sensitizer that suppresses hepatic glucose production in vivo. The antidiabetic effect of MTZ does not appear to be a function of its known activity as a CAI. The additive glucose-lowering effect of MTZ together with metformin highlights the potential utility for the management of type 2 diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/db11-0578","type":"journal-article","created":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T06:29:45Z","timestamp":1337063385000},"page":"2146-2154","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":26,"title":["Methazolamide Is a New Hepatic Insulin Sensitizer That Lowers Blood Glucose In Vivo"],"prefix":"10.2337","volume":"61","author":[{"given":"Nicky","family":"Konstantopoulos","sequence":"first","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Molero","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean L.","family":"McGee","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briana","family":"Spolding","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Connor","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"de Vries","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Wanyonyi","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Fahey","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shona","family":"Morrison","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Swinton","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Jones","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Cooper","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Garcia-Guerra","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria C.","family":"Foletta","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Krippner","sequence":"additional","affiliation":[{"name":"Verva Pharmaceuticals, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofianos","family":"Andrikopoulos","sequence":"additional","affiliation":[{"name":"Department of Medicine (AH), University of Melbourne, Austin Hospital, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken R.","family":"Walder","sequence":"additional","affiliation":[{"name":"Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2012,7,17]]},"reference":[{"key":"2022031223074691000_B1"},{"key":"2022031223074691000_B2","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.2337\/diabetes.53.2007.S119","article-title":"\u03b2-Cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes","volume":"53","author":"Robertson","year":"2004","journal-title":"Diabetes"},{"key":"2022031223074691000_B3","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1210\/jc.2009-1966","article-title":"Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know","volume":"95","author":"Smith","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031223074691000_B4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1152\/physiolgenomics.00115.2010","article-title":"A gene expression signature for insulin resistance","volume":"43","author":"Konstantopoulos","year":"2011","journal-title":"Physiol Genomics"},{"key":"2022031223074691000_B5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ng1305","article-title":"Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation","volume":"36","author":"Stegmaier","year":"2004","journal-title":"Nat Genet"},{"key":"2022031223074691000_B6","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A gene-expression signature as a predictor of survival in breast cancer","volume":"347","author":"van de Vijver","year":"2002","journal-title":"N Engl J Med"},{"key":"2022031223074691000_B7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1152\/physrev.00011.2004","article-title":"Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters","volume":"85","author":"Gamba","year":"2005","journal-title":"Physiol Rev"},{"key":"2022031223074691000_B8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1159\/000082314","article-title":"Long-term adaptation of renal ion transporters to chronic diuretic treatment","volume":"24","author":"Kim","year":"2004","journal-title":"Am J Nephrol"},{"key":"2022031223074691000_B9","first-page":"S32","article-title":"Na+:HCO3- cotransporters (NBC): expression and regulation in the kidney","volume":"15","author":"Soleimani","year":"2002","journal-title":"J Nephrol"},{"key":"2022031223074691000_B10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/138161208783877947","article-title":"Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr Pharm Des"},{"key":"2022031223074691000_B11","doi-asserted-by":"crossref","first-page":"C125","DOI":"10.1152\/ajpcell.00247.2006","article-title":"Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells","volume":"292","author":"Wu","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"2022031223074691000_B12","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/diabetes.49.12.2063","article-title":"Mechanism by which metformin reduces glucose production in type 2 diabetes","volume":"49","author":"Hundal","year":"2000","journal-title":"Diabetes"},{"key":"2022031223074691000_B13","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2337\/diabetes.53.4.1052","article-title":"Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?","volume":"53","author":"Brunmair","year":"2004","journal-title":"Diabetes"},{"key":"2022031223074691000_B14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"El-Mir","year":"2000","journal-title":"J Biol Chem"},{"key":"2022031223074691000_B15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem J"},{"key":"2022031223074691000_B16","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/db07-1552","article-title":"Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action","volume":"57","author":"Turner","year":"2008","journal-title":"Diabetes"},{"key":"2022031223074691000_B17","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.2337\/diabetes.53.12.3258","article-title":"Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms","volume":"53","author":"Cleasby","year":"2004","journal-title":"Diabetes"},{"key":"2022031223074691000_B18","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2337\/db09-0328","article-title":"Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo","volume":"58","author":"Edgerton","year":"2009","journal-title":"Diabetes"},{"key":"2022031223074691000_B19","doi-asserted-by":"crossref","first-page":"12121","DOI":"10.1073\/pnas.0812547106","article-title":"Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with type 2 diabetes","volume":"106","author":"Samuel","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031223074691000_B20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cmet.2007.03.004","article-title":"Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver","volume":"5","author":"Burgess","year":"2007","journal-title":"Cell Metab"},{"key":"2022031223074691000_B21","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1172\/JCI43661","article-title":"An energetic tale of AMPK-independent effects of metformin","volume":"120","author":"Miller","year":"2010","journal-title":"J Clin Invest"},{"key":"2022031223074691000_B22","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1172\/JCI40671","article-title":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state","volume":"120","author":"Foretz","year":"2010","journal-title":"J Clin Invest"},{"key":"2022031223074691000_B23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/db07-0381","article-title":"Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP","volume":"57","author":"Kim","year":"2008","journal-title":"Diabetes"},{"key":"2022031223074691000_B24","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin","volume":"310","author":"Shaw","year":"2005","journal-title":"Science"},{"key":"2022031223074691000_B25","doi-asserted-by":"crossref","first-page":"L178","DOI":"10.1152\/ajplung.00205.2006","article-title":"Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition","volume":"292","author":"H\u00f6hne","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2022031223074691000_B26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000441-200001000-00002","article-title":"Diuretic complications","volume":"319","author":"Greenberg","year":"2000","journal-title":"Am J Med Sci"},{"key":"2022031223074691000_B27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1748-1716.1988.tb08300.x","article-title":"Furosemide causes acute and long-term hyperglycaemia and reduces glucose tolerance in mice","volume":"132","author":"Sandstr\u00f6m","year":"1988","journal-title":"Acta Physiol Scand"},{"key":"2022031223074691000_B28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/10641960701743964","article-title":"Metabolic side effects and cardiovascular events of diuretics: should a diuretic remain the first choice therapy in hypertension treatment? The case of yes","volume":"29","author":"Papadopoulos","year":"2007","journal-title":"Clin Exp Hypertens"},{"key":"2022031223074691000_B29","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1152\/jappl.1993.75.3.1186","article-title":"Carbonic anhydrases in cytosol, nucleus, and membranes of rat liver","volume":"75","author":"Dodgson","year":"1993","journal-title":"J Appl Physiol"},{"key":"2022031223074691000_B30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0003-9861(86)90066-4","article-title":"Inhibition of CA V decreases glucose synthesis from pyruvate","volume":"251","author":"Dodgson","year":"1986","journal-title":"Arch Biochem Biophys"},{"key":"2022031223074691000_B31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0304-4165(90)90040-4","article-title":"Expression of hepatic mitochondrial carbonic anhydrase V","volume":"1036","author":"Carter","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"2022031223074691000_B32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0003-9861(90)90597-R","article-title":"Differential regulation of hepatic carbonic anhydrase isozymes in the streptozotocin-diabetic rat","volume":"277","author":"Dodgson","year":"1990","journal-title":"Arch Biochem Biophys"},{"key":"2022031223074691000_B33","first-page":"730","article-title":"The pharmacology of methazolamide in relation to the treatment of glaucoma","volume":"16","author":"Maren","year":"1977","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022031223074691000_B34","doi-asserted-by":"crossref","first-page":"L1002","DOI":"10.1152\/ajplung.00161.2006","article-title":"Inhibition of hypoxia-induced calcium responses in pulmonary arterial smooth muscle by acetazolamide is independent of carbonic anhydrase inhibition","volume":"292","author":"Shimoda","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2022031223074691000_B35","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1016\/S0021-9258(17)37133-8","article-title":"Glycogenesis from glucose and ureagenesis in isolated perfused rat livers. Influence of ammonium ion, norvaline, and ethoxyzolamide","volume":"269","author":"Bode","year":"1994","journal-title":"J Biol Chem"},{"key":"2022031223074691000_B36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0020-711X(78)90121-0","article-title":"Action of acetazolamide on liver pyruvate carboxylase activity, glycogenolysis and gluconeogenesis of mice","volume":"9","author":"Cao","year":"1978","journal-title":"Int J Biochem"},{"key":"2022031223074691000_B37","first-page":"301","article-title":"Effect of acetazolamide on insulin sensitivity in dogs with alloxan diabetes","volume":"22","author":"Das","year":"1978","journal-title":"Indian J Physiol Pharmacol"},{"key":"2022031223074691000_B38","first-page":"169","article-title":"Effects of acetazolamide on insulin release, serum glucose and insulin, glucose tolerance, and alloxan sensitivity of mice","volume":"58","author":"Boquist","year":"1980","journal-title":"Med Biol"},{"key":"2022031223074691000_B39","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1152\/jappl.1983.55.2.628","article-title":"Calculation of substrate oxidation rates in vivo from gaseous exchange","volume":"55","author":"Frayn","year":"1983","journal-title":"J Appl Physiol"},{"key":"2022031223074691000_B40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1949.sp004363","article-title":"New methods for calculating metabolic rate with special reference to protein metabolism","volume":"109","author":"Weir","year":"1949","journal-title":"J Physiol"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/61\/8\/2146\/561622\/2146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/61\/8\/2146\/561622\/2146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:27:06Z","timestamp":1667406426000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/61\/8\/2146\/33887\/Methazolamide-Is-a-New-Hepatic-Insulin-Sensitizer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,17]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2012,7,17]]},"published-print":{"date-parts":[[2012,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db11-0578","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,17]]}}}